Literature DB >> 31477461

The multi-disciplinary team - Who is liable when things go wrong?

Talisa Ross1, Nikhil Pawa2.   

Abstract

The question of culpability over decisions made by the multi-disciplinary team (MDT) is a contentious one. Currently, all members present remain responsible for the MDT's decision, but it is unclear whether the onus of decision making lies with the patient's "lead clinician", and how straight to test pathways (bypassing a consultation with a specialist prior to MDT discussion) impact on this. Additionally, should a non-consensus recommendation be reached, it remains undetermined how dissenting members of the MDT would be viewed in a court of law. Given these uncertainties, there remains a substantial risk of legal action against the MDT as a group. Until case law materialises to provide clarification on these issues, clinicians should improve their awareness over their medico-legal responsibilities and proceed with caution. Crown
Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Culpability; Liability; MDT; Medico-legal; Multi-disciplinary team

Year:  2019        PMID: 31477461     DOI: 10.1016/j.ejso.2019.08.020

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  1 in total

1.  Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM).

Authors:  Maria Antonietta Mazzei; Giulio Bagnacci; Francesco Gentili; Iacopo Capitoni; Gianni Mura; Daniele Marrelli; Roberto Petrioli; Luca Brunese; Salvatore Cappabianca; Marco Catarci; Maurizio Degiuli; Giovanni De Manzoni; Marco De Prizio; Annibale Donini; Uberto Fumagalli Romario; Luigi Funicelli; Andrea Laghi; Giuseppe Minetti; Paolo Morgagni; Enrico Petrella; Frida Pittiani; Stefano Rausei; Laura Romanini; Riccardo Rosati; Amato Antonio Stabile Ianora; Guido A M Tiberio; Luca Volterrani; Franco Roviello; Roberto Grassi
Journal:  Eur Radiol       Date:  2021-08-12       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.